Connection
Christina Chambers to Certolizumab Pegol
This is a "connection" page, showing publications Christina Chambers has written about Certolizumab Pegol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.142 |
|
|
|
-
Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. Arthritis Rheumatol. 2018 09; 70(9):1399-1407.
Score: 0.142